This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genmab A+s. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Sven Berger: Innovator in Cancer Treatment
Introduction
Sven Berger is a notable inventor based in Haute-Savoie, France. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel therapeutic methods.
Latest Patents
Sven Berger holds a patent for "Methods and antibodies for treating cancer." This invention relates to novel methods for the treatment of tumors, which involve the administration of a bispecific antibody or a combination of two or more non-cross-blocking antibodies that recognize the same target antigen or antigenic complex. In particular, the invention focuses on a method for inducing complement-mediated cell killing in the treatment of a tumor. This method comprises the combined administration, to a human being in need thereof, of a first antibody and a second antibody.
Career Highlights
Sven Berger is associated with Genmab A/S, a company known for its focus on developing differentiated antibody therapeutics for the treatment of cancer. His work has contributed to advancing the understanding and treatment of tumors, showcasing his commitment to improving patient outcomes.
Collaborations
Sven has collaborated with esteemed colleagues such as Jan Van De Winkel and Paul Parren. These collaborations have further enhanced the research and development efforts in the field of cancer treatment.
Conclusion
Sven Berger's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. His contributions continue to pave the way for advancements in therapeutic methods for cancer patients.